RT Journal Article
SR Electronic
T1 Methods for a study of Anticipatory and Preventive multidisciplinary Team Care in a family practice
JF Canadian Family Physician
JO Can Fam Physician
FD The College of Family Physicians of Canada
SP e73
OP e83
VO 56
IS 2
A1 Dahrouge, Simone
A1 Hogg, William
A1 Lemelin, Jacques
A1 Liddy, Clare
A1 Legault, Frances
YR 2010
UL http://www.cfp.ca/content/56/2/e73.abstract
AB BACKGROUND T o examine the methodology used to evaluate whether focusing the work of nurse practitioners and a pharmacist on frail and at-risk patients would improve the quality of care for such patients. DESIGN Evaluation of methodology of a randomized controlled trial including analysis of quantitative and qualitative data over time and analysis of cost-effectiveness. SETTING A single practice in a rural area near Ottawa, Ont. PARTICIPANTS A total of 241 frail patients, aged 50 years and older, at risk of experiencing adverse health outcomes. INTERVENTION At-risk patients were randomly assigned to receive Anticipatory and Preventive Team Care (from their family physicians, 1 of 3 nurse practitioners, and a pharmacist) or usual care. MAIN OUTCOME MEASURES The principal outcome for the study was the quality of care for chronic disease management. Secondary outcomes included other quality of care measures and evaluation of the program process and its cost-effectiveness. This article examines the effectiveness of the methodology used. Quantitative data from surveys, administrative databases, and medical records were supplemented with qualitative information from interviews, focus groups, work logs, and study notes. CONCLUSION Three factors limit our ability to fully demonstrate the potential effects of this team structure. For reasons outside our control, the intervention duration was shorter than intended; the practice’s physical layout did not facilitate interactions between the care providers; and contamination of the intervention effect into the control arm cannot be excluded. The study used a randomized design, relied on a multifaceted approach to evaluating its effects, and used several sources of data. TRIAL REGISTRATION NUMBER NCT00238836 (CONSORT).